ProPhase Labs Just Filed Its Quarterly Report: A reconciliation of...

A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended March 31, 2016     Three Months Ended March 31, 2015  
    Loss     Shares     EPS     Loss     Shares     EPS  
Basic                                                
loss per share   $ (1,336 )     17,081     $ (0.08 )   $ (1,380 )     15,892     $ (0.09 )
Dilutives:                                                
Options     -       -       -       -       -       -  
Diluted loss per share   $ (1,336 )     17,081     $ (0.08 )   $ (1,380 )     15,892     $ (0.09 )

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017
Departure of Directors or Certain - Aug. 24, 2017

Auto Refresh

Feedback